IDH1 mutations were not associated with either PD-1+ TIL or FOXP3+ TIL expression (P = 0.895 for PD-1 and P = 0.711 for FOXP3), regardless of the glioma's grade or pathology. The gene discussed is IDH1; the disease is central nervous system cancer.